ViaDerma, Inc.

Total Valuation

ViaDerma, Inc. carries a market capitalization of 493,484.00, placing it among publicly traded companies globally. Its enterprise value stands at 11.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

ViaDerma, Inc. currently has 137,322.00 shares outstanding.

Valuation Ratios

ViaDerma, Inc. trades at a trailing price-to-earnings ratio of 2.38. The price-to-sales ratio is 0.31, and the price-to-book ratio stands at 0.21.

Enterprise Valuation

On an enterprise value basis, ViaDerma, Inc. trades at an EV/EBITDA multiple of 1.69 and an EV/FCF ratio of 0.75. The EV/Sales ratio of 0.65 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.10 provides insight into valuation relative to core operating earnings.

Financial Position

ViaDerma, Inc. maintains a current ratio of 2.15, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 20.75, indicating elevated leverage, while an interest coverage ratio of 10.13 demonstrates strong ability to service its debt obligations.

Financial Efficiency

ViaDerma, Inc. posts a return on equity of 9.36 and a return on invested capital of 7.06.

Taxes

Over the trailing twelve months, ViaDerma, Inc. has paid 766,995.00 in income taxes, reflecting an effective tax rate of 24.91.

Stock Price Statistics

ViaDerma, Inc.'s stock has declined approximately -20% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Income Statement

Over the trailing twelve months, ViaDerma, Inc. generated 17.80M in revenue and converted that into 2.31M in net income, yielding earnings per share of 16.84. EBITDA reached 6.84M, while operating income came in at 3.74M.

Balance Sheet

ViaDerma, Inc. holds 1.19M in cash and equivalents against 7.28M in total debt, resulting in a net debt position of 6.10M. Total book value stands at 25.82M, with working capital of 9.05M providing operational flexibility.

Cash Flow

ViaDerma, Inc. produced 6.22M in operating cash flow over the past twelve months. After subtracting -8.68M in capital expenditures, free cash flow totaled -2.46M - equivalent to -17.92 per share.

Margins

ViaDerma, Inc. operates with a gross margin of 28.90, reflecting its pricing power and cost economics. The operating margin of 21.02 and net profit margin of 12.99 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

ViaDerma, Inc.'s most recent stock split took place on August 7, 2014 with a 50:1 split ratio.

Scores

ViaDerma, Inc. posts an Altman Z-Score of 1.99, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.